PEARLY TALE LIMITED – Trademark Portfolio
Entity Type: 99
PEARLY TALE LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MOVALUES, WILDLINERS, and PEARLY TALE. The owner is based in VICTORIA.
SUITE 9, ANSUYA ESTATE, REVOLUTION
AVENUE
VICTORIA , SC
Showing of trademarks Trademarks
Trademark Classifications
PEARLY TALE LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does PEARLY TALE LIMITED have?
PEARLY TALE LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does PEARLY TALE LIMITED file in?
PEARLY TALE LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 27 (Floor Coverings). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are PEARLY TALE LIMITED's most well-known trademarks?
PEARLY TALE LIMITED's registered trademark portfolio includes well-known marks such as MOVALUES, WILDLINERS, and PEARLY TALE. These are among 3 currently registered trademarks in the portfolio.
What is PEARLY TALE LIMITED's trademark registration success rate?
PEARLY TALE LIMITED has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.